OTCMKTS:VBIO

Vitality Biophar Stock Insider Trading

Healthcare > Biotechnology

Buy VBIO

*Your capital is at risk

$0.83

+0 (+0%)

At Close: Jun 03, 2026

Vitality Biophar Stock Insider Power

Based on the 53 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 17.24M and sold 1.94M VBIO shares in the last 53 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 53 transactions)	100.00
● Buy	17.24M shares
● Sell	1.94M shares
92% Buy Activity Weak Positive Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jan 25, 2019 Buy	Common Stock, par value $0.001 per share J-Other	Loconti Joseph E. 10 Percent Owner	10% Owner	907 292 Value: $0
Jan 25, 2019 Buy	Common Stock, par value $0.001 per share J-Other	Loconti Joseph E. 10 Percent Owner	10% Owner	930 557 Value: $0
Jan 25, 2019 Sell	Warrant J-Other	Loconti Joseph E. 10 Percent Owner	10% Owner	166 667 Value: $333.3K
Jan 25, 2019 Sell	Warrant J-Other	Loconti Joseph E. 10 Percent Owner	10% Owner	1 556 666 Value: $4.67M
Jan 25, 2019 Buy	Common Stock, par value $0.001 per share J-Other	Loconti Joseph E. 10 Percent Owner	10% Owner	3 540 763 Value: $0
Jan 25, 2019 Buy	Common Stock J-Other	Feighan Edward F Director	Director	1 402 813 Value: $0
Jan 25, 2019 Buy	Common Stock J-Other	Cavanaugh Michael R. Director	Director	572 291 Value: $0
Jan 25, 2019 Buy	Common Stock J-Other	Feighan Edward F Director	Director	467 604 Value: $0
Jan 25, 2019 Sell	Common Stock Warrants (right to buy) J-Other	Cavanaugh Michael R. Director	Director	50 000 Value: $150.0K
Jan 25, 2019 Sell	Common Stock Warrants (right to buy) J-Other	Feighan Edward F Director	Director	167 500 Value: $502.5K
Nov 15, 2018 Buy	Common Stock	Feighan Edward F Director	Director	0 Value: $0
Nov 15, 2018 Buy	Common Stock	Feighan Edward F Director	Director	0 Value: $0
Nov 15, 2018 Buy	Common Stock	Cavanaugh Michael R. Director	Director	0 Value: $0
Oct 22, 2018 Buy	Common Stock Warrants (right to buy)	Feighan Edward F Director	Director	167 500 Value: $502.5K
Oct 22, 2018 Buy	Common Stock Warrants (right to buy)	Feighan Edward F Director	Director	502 500 Value: $1.51M
Oct 22, 2018 Buy	Common Stock Warrants (right to buy)	Cavanaugh Michael R. Director	Director	50 000 Value: $150.0K
Oct 22, 2018 Buy	Common Stock, par value $0.001 per share	Loconti Joseph E. 10 Percent Owner	10% Owner	0 Value: $0
Oct 22, 2018 Buy	Common Stock, par value $0.001 per share	Loconti Joseph E. 10 Percent Owner	10% Owner	0 Value: $0
Oct 22, 2018 Buy	Common Stock, par value $0.001 per share	Loconti Joseph E. 10 Percent Owner	10% Owner	0 Value: $0
Oct 22, 2018 Buy	Common Stock, par value $0.001 per share	Loconti Joseph E. 10 Percent Owner	10% Owner	0 Value: $0
Oct 22, 2018 Buy	Common Stock, par value $0.001 per share	Loconti Joseph E. 10 Percent Owner	10% Owner	0 Value: $0
Oct 22, 2018 Buy	Warrant	Loconti Joseph E. 10 Percent Owner	10% Owner	1 556 666 Value: $4.67M
Aug 29, 2018 Buy	Warrant	Loconti Joseph E. 10 Percent Owner	10% Owner	166 667 Value: $333.3K
Jul 15, 2018 Buy	Employee Stock Option (Right to Buy)	Mckilligan Richard CFO, Secretary And Counsel	C-Suite Officer	370 234 Value: $185.1K
Jun 27, 2018 Buy	Employee Stock Option (Right to Buy)	Mckilligan Richard CFO, Secretary And Counsel	C-Suite Officer	75 000 Value: $135.8K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT VITALITY BIOPHAR

Vitality Biopharma, Inc. engages in the development of cannabinoid pharmaceuticals for the treatment of inflammatory disorders in the United States. The company is developing tetrahydrocannabinol glycoside (VBX-100), an oral cannabinoid prodrug for inflammatory bowel disease and irritable bowel syndromes. The company was formerly known as Stevia First Corp. and changed its name to Vitality Biopharma, Inc. in July 2016. Vitality Biopharma, Inc. wa...

Read Full Profile Here